885
Views
3
CrossRef citations to date
0
Altmetric
Review

Cardiac rehabilitation and its effects on cognition in patients with coronary artery disease and heart failure

, &
Pages 645-652 | Received 18 Apr 2018, Accepted 06 Aug 2018, Published online: 21 Aug 2018

References

  • Luchsinger JA, Mayeux R. Cardiovascular risk factors and Alzheimer’s disease. Curr Atheroscler Rep. 2004;6:261–266.
  • Whitmer RA, Sidney S, Selby J, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–281.
  • Qiu C, Xu W, Winblad B, et al. Vascular risk profiles for dementia and Alzheimer’s disease in very old people: a population-based longitudinal study. J Alzheimers Dis. 2010;20:293–300.
  • Abete P, Della-Morte D, Gargiulo G, et al. Cognitive impairment and cardiovascular diseases in the elderly. a heart-brain continuum hypothesis. Ageing Res Rev. 2014;18:41–52.
  • Schievink SHJ, Van Boxtel MPJ, Deckers K, et al. Cognitive changes in prevalent and incident cardiovascular disease: a 12-year follow-up in the Maastricht Aging Study (MAAS). Eur Heart J. 2017;38:3222–3228.
  • Eggermont LHP, De Boer K, Muller M, et al. Cardiac disease and cognitive impairment: a systematic review. Heart. 2012;98:1334–1340.
  • Barclay LL, Weiss EM, Mattis S, et al. Unrecognized cognitive impairment in cardiac rehabilitation patients. J Am Geriatr Soc. 1988;36:22–28.
  • Andreescu C, Teverovsky E, Fu B, et al. Old worries and new anxieties: behavioral symptoms and mild cognitive impairment in a population study. Am J Geriatr Psychiatry. 2014;22:274–284.
  • Cannon JA, Moffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. J Card Fail. 2017;23:464–475.
  • Gure TR, Blaum CS, Giordani B, et al. Prevalence of cognitive impairment in older adults with heart failure. J Am Geriatr Soc. 2012;60:1724–1729.
  • Rusanen M, Kivipelto M, Levalahti E, et al. Heart diseases and long-term risk of dementia and Alzheimer’s disease: a population-based CAIDE study. J Alzheimers Dis. 2014;42:183–191.
  • Vogels RL, Scheltens P, Schroeder-Tanka JM, et al. Cognitive impairment in heart failure: a systematic review of the literature. Eur J Heart Fail. 2007;9:440–449.
  • Zuccalà G, Pedone C, Cesari M, et al. The effects of cognitive impairment on mortality among hospitalized patients with heart failure. Am J Med. 2003;115:97–103.
  • Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an educational and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83–89.
  • Alagiakrishnan K, Mah D, Ahmed A, et al. Cognitive decline in heart failure. Heart Fail Rev. 2016;21:661–673.
  • Alagiakrishnan K, Mah D, Dyck JR, et al. Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the golden standard European consortium criteria. Int J Cardiol. 2017;228:558–562.
  • Bratzke-Bauer LC, Pozehl BJ, Paul SM, et al. Neuropsychological patterns differ by type of left ventricle dysfunction in heart failure. Arch Clin Neuropsychol. 2013;28:114–124.
  • Jefferson AL, Himali JJ, Beiser AS, et al. Cardiac index is associated with brain aging: the Framingham heart study. Circulation. 2010;122:690–697.
  • Deckers K, Schievink SHJ, Rodriquez MMF, et al. Coronary heart disease and risk for cognitive impairment or dementia: systematic review and meta-analysis. PLoS ONE. 2017;12:e0184244.
  • Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand. 2009;119:252–265.
  • Li J, Wang YJ, Zhang M, et al. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–1491.
  • Roberts RO, Geda YE, Knopman DS, et al. Cardiac disease associated with increased risk of non-amnestic cognitive impairment: stronger effect on women. JAMA Neurol. 2013;70:374–382.
  • Haring B, Leng X, Robinson J, et al. Cardiovascular disease and cognitive decline in postmenopausal women: results from the women’s health initiative memory study. J Am Heart Assoc. 2013;2:e000369.
  • Eriksson UK, Bennet AM, Gatz M, et al. Nonstroke cardiovascular disease and risk of Alzheimer disease and dementia. Alzheimer Dis Assoc Disord. 2010;24:213–219.
  • Singh-Manoux A, Britton AR, Marmot M. Vascular disease and cognitive function: evidence from the Whitehall II study. J Am Geriatr Soc. 2003;51:1445–1450.
  • Ahlgren E, Lundqvist A, Nordlund A, et al. Neurocognitive impairment and driving performance after coronary artery bypass surgery. Eur J Cardiothorac Surg. 2003;23:334–340.
  • Cibelli M, Fidalgo AR, Terrando N, et al. Role of interleukin-β in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360–368.
  • Terrando N, Monaco C, Ma D, et al. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci USA. 2010;107:20518–20522.
  • Corona AW, Fenn AM, Godbout JP. Cognitive and behavioral consequences of impaired immunoregulation in aging. J Neuroimmune Pharmacol. 2012;7:7–23.
  • Selnes OA, Gottesman RF, Grega MA, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012;366:250–257.
  • Kennedy ED, Choy KC, Alston RP, et al. Cognitive outcome after on- and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2013;27:253–265.
  • Lip GY, Beevers DG. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ 1995;311:1361–1363.
  • Stevenson WG, Stevenson LW. Atrial fibrillation in heart failure. N Engl J Med. 1999;341:910–911.
  • Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30:1038–1045.
  • Luo J, Li H, Qin X, et al. Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: a systematic review and meta-analysis. Int J Cardiol. 2018;265:125–131.
  • Kwok CS, Loke YK, Hale R, et al. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis. Neurology. 2011;76:914–922.
  • Santangeli P, Di Biase L, Bai R, et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm. 2012;9:1761–1768.
  • Cacciatore F, Testa G, Langellotto A, et al. Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: a 10-year study. Dement Geriatr Cogn Disord. 2012;34:143–148.
  • Harada M, Van Wagoner DR, Nattel S. Role of inflammation in atrial fibrillation pathophysiology and management. Circulation. 2015;79(3):495–502.
  • Jabati S, Fareed J, Liles J, et al. Biomarkers of inflammation, thrombogenesis, and collagen turnover in patients with atrial fibrillation. Clin Appl Thromb Hemost. 2018 Jul;24(5):718–723.
  • Zhang Z-G, Li Y, Ng CT, et al. Inflammation in Alzheimer’s disease and molecular genetics: recent update. Arch Immunol Ther Exp. 2015;63:333–344.
  • Ferrario CM, Strawn WB. Role of the renin–angiotensin–aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006;98:121–128.
  • Yagi S1, Akaike M, Ise T, et al. Renin-angiotensin-aldosterone system has a pivotal role in cognitive impairment. Hypertens Res. 2013 Sep;36(9):753–758.
  • Franklin BA, Hall L, Timmis GC. Contemporary cardiac rehabilitation services. Am J Cardiol. 1997;79:1075–1077.
  • Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. Circulation. 2011;22:2459–2473.
  • Galve E, Alegría E, Cordero A, et al. Update in cardiology: vascular risk and cardiac rehabilitation. Rev Esp Cardiol Engl Ed. 2014;67:203–210.
  • Piepoli MF, Corrà U, Benzer W, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the cardiac rehabilitation section of the European association of cardiovascular prevention and rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010;17:1–17.
  • Thomas RJ. Cardiac rehabilitation/secondary prevention programs. A raft for the rapids: why have we missed the boat? Circulation. 2007;116:1644–1646.
  • Boyden T, Rubenfire M, Franklin B. Will increasing referral to cardiac rehabilitation improve participation? Prev Cardiol. 2010;13:198–202.
  • Ades PA, Waldmann ML, Polk DM, et al. Referral patterns and exercise response in the rehabilitation of female coronary patients aged ≥ 62 years. Am J Cardiol. 1992;69:1422–1425.
  • Ades PA, Waldmann ML, McCann WJ, et al. Predictors of cardiac rehabilitation participation in older coronary patients. Arch Intern Med. 1992;152:1033–1035.
  • Grace SL, Evindar A, Abramson B, et al. Physician management preferences for cardiac patients: factors affecting referral to cardiac rehabilitation. Can J Cardiol. 2004;20:1101–1107.
  • Beswick AD, Rees K, West RR, et al. Improving uptake and adherence in cardiac rehabilitation: literature review. J Adv Nurs. 2005;49:538–555.
  • Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention and the council on nutrition, physical activity, and metabolism (subcommittee on physical activity). Circulation. 2003;107:3109–3116.
  • Carli F, Zavorsky GS. Optimizing functional exercise capacity in the elderly surgical population. Curr Opin Clin Nutr Metab Care. 2005;8:23–32.
  • Weinkam S, Cook N. Cardiac surgery prehabilitation. Can J Cardiol. 2017;33:S230.
  • Arthur HM, Daniels C, McKelvie R, et al. Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Ann Intern Med. 2000 Aug 15;133(4):253–262.
  • Kawano T, Eguchi S, Iwata H, et al. Impact of preoperative enrichment on prevention of development of cognitive impairment following abdominal surgery in a rat model. Anaesthesiology. 2015;123:160–170.
  • Justin BN, Turek M, Hakim AM. Heart disease as a risk factor for dementia. Clin Epidemiol. 2013;5:135–145.
  • Ikram MA, van Oijen M, de Jong FJ, et al. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke. 2008;39:1421–1426.
  • Gruhn N, Larsen FS, Boesgaard S, et al. Cerebral blood flow in patients. with chronic heart failure before and after heart transplantation. Stroke. 2001;32:2530–2533.
  • Radak Z, Hart N, Sarga L, et al. Exercise plays a preventive role against Alzheimer’s disease. J Alzheimer’s Dis. 2010;20:777–783.
  • Alagiakrishnan K, McCracken P, Feldman H. Treating vascular risk factors and maintaining vascular health: is this the way towards successful cognitive ageing and preventing cognitive decline? Postgrad Med J. 2006;82:101–105.
  • Swain RA, Harris AB, Wiener EC, et al. Prolonged exercise induces angiogenesis and increases cerebral blood flow volume in primary motor cortex of the rat. Neuroscience. 2003;117:1037–1046.
  • Colcombe SJ, Kramer AF, Erickson KI, et al. Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci USA. 2004;101:3316–3321.
  • Hillman CH, Erickson KI, Kramer AF. Be smart, exercise your heart: exercise effects on brain and cognition. Nat Rev Neurosci. 2008;9:58–65.
  • Ten Brinke LF, Bolandzadeh N, Nagamatsu LS, et al. Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomized controlled trial. Br J Sports Med. 2015;49:248–254.
  • Middleton LE, Mitnitski A, Fallah N, et al. Changes in cognition and mortality in relation to exercise in late life: a population based study. PLoS One. 2008;3:e3124.
  • Anazodo UC, Shoemaker JK, Suskin N, et al. An investigation of changes in regional gray matter volume in cardiovascular disease patients, pre and post cardiovascular rehabilitation. Neuroimage Clin. 2013;3:388–392.
  • Anazodo UC, Shoemaker JK, Suskin N, et al. Impaired cerebrovascular function in coronary artery disease patients and recovery following cardiac rehabilitation. Front Aging Neurosci. 2016;7:1–13.
  • Dalal H, Evans PH, Campell JL. Recent development in secondary prevention and cardiac rehabilitation after acute myocardial infarction. BMJ. 2004;382:693–697.
  • Clark AM, Harting L, Vandermeer B, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659–672.
  • Erickson KI, Kramer AF. Aerobic exercise effects on cognitive and neural plasticity in older adults. Br J Sports Med. 2009;43:22–24.
  • Makizako H, Liu-Ambrose T, Shimada H, et al. Moderate-intensity physical activity, hippocampal volume, and memory in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci. 2015;70:480–486.
  • Gunstad J, MacGregor KL, Paul RH. Cardiac rehabilitation improves cognitive performance in older adults with cardiovascular disease. J Cardiopulm Rehabil. 2005;25:173–176.
  • Stanek KM, Gunstad J, Spitznagel MB. Improvements in cognitive function following cardiac rehabilitation for older adults with cardiovascular disease. Int J Neurosci. 2011;121:86–93.
  • Tanne D, Freimark D, Poreh A, et al. Cognitive functions in severe congestive heart failure before and after an exercise training program. Int J Cardiol. 2005;103:145–149.
  • Alosco ML, Spitznagel MB, Cohen R, et al. Cardiac rehabilitation is associated with lasting improvement in cognitive function in older adults with heart failure. Acta Cardiol. 2014;69:407–414.
  • Garcia S, Alosco ML, Spitznagel MB, et al. Cardiovascular fitness associated with cognitive performance in heart failure patients enrolled in cardiac rehabilitation. BMC Cardiovasc Disord. 2013;13:29.
  • Nasreddine ZS, Phillips NA, Bédirian V. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–699.
  • Molloy DW, Standish TI. A guide to the standardized mini-mental state examination. Int Psychogeriatr. 1997;9 Suppl 1:87–94.
  • Zainal NH, Silva E, Lim LLH, et al. Psychometric properties of Alzheimer’s disease assessment scale - Cognitive impairment subscale for mild cognitive impairment and mild Alzheimer’s disease patients in an asian context. Ann Acad Med Singapore. 2016;45:273–283.
  • Galvin JE, Roe CM, Powlishta KK, et al. The ADS 8, a brief informant interview to detect dementia. Neurology. 2005;65:559–564.
  • Huppert FA, Jorm AF, Brayne C, et al. Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia. Aging Neuropsychol Cogn. 1996;3:201–214.
  • Alagiakrishnan K, Zhao N, Mereu L, et al. Montreal Cognitive Assessment is superior to standardized mini-mental status exam in detecting mild cognitive impairment in the middle-aged and elderly patients with type 2 diabetes mellitus. Biomed Res Int. 2013;2013:186106.
  • Davis KK, Allen JK. Identifying cognitive impairment in heart failure: a review of screening measures. Heart Lung. 2013;42:92–97.
  • Breteler MM, Claus JJ, Grobbee DE, et al. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. BMJ. 1994;308:1604–1608.
  • Kalmijn S, Feskens EJ, Launer LJ, et al. Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men. Stroke. 1996;27:2230–2235.
  • Salzwedel A, Heidler MD, Haubold K, et al. Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation. Vasc Health Risk Manag. 2017;13:55–60.
  • Volonghi I, Pendelbury ST, Welch SJ, et al. Cognitive outcomes after acute coronary syndrome: a population based comparison with transient ischaemic attack and minor stroke. Heart. 2013;99:1509–1514.
  • Athilingam P, King KB, Burgin SW, et al. Montreal Cognitive Assessment and mini-mental status examination compared as cognitive screening tools in heart failure. Heart Lung. 2011;40:521–529.
  • Hawkins MA, Cathright EC, Gunstad J, et al. The MoCA and MMSE as screeners for cognitive impairment in a heart failure population: a study with comprehensive neuropsychological testing. Heart Lung. 2014;43:462–468.
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.
  • Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI working group of the European consortium on Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2006;77:714–718.
  • Brayne C, Gill C, Huppert FA, et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord. 1998;9:175–180.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.